Sara R. Oliveira
Lisbon, 1649003, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Oliveira et al. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice. Int. J. Mol. Sci. 2021, 22, 5289.
Journal: International journal of molecular sciences
Published: December 31, 2024
Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice.
Journal: International journal of molecular sciences
Published: April 16, 2021
miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson's Disease.
Journal: Frontiers in cell and developmental biology
Published: January 30, 2021
Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology.
Journal: Biomolecules
Published: May 08, 2020
Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson's disease.
Journal: Cell death & disease
Published: August 22, 2019
Mechanism and disease implications of necroptosis and neuronal inflammation.
Journal: Cell death & disease
Published: June 27, 2018
Loss of Microglial Parkin Inhibits Necroptosis and Contributes to Neuroinflammation.
Journal: Molecular neurobiology
Published: May 14, 2018
Phenotypic screening identifies a new oxazolone inhibitor of necroptosis and neuroinflammation.
Journal: Cell death discovery
Published: March 26, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026